THE EVALUATION OF SERUM ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) LEVELS AND ITS RELATIONSHIP WITH CLINICAL OUTCOME IN PATIENTS WITH COVID-19

被引：0
|
作者：
Hosseinib, M. [1 ]
Hashemi-Bajgani, S. -M. [2 ,3 ]
Fekri, M. Samareh [1 ,2 ,4 ]
机构：
[1] Kerman Univ Med Sci, Afzalipour Hosp, Dept Internal Med, Sch Med, Kerman, Iran
[2] Kerman Univ Med Sci, Afzalipour Hosp, Kerman, Iran
[3] Sch Med, Dept Internal Med 1, Yazd, Iran
[4] Sch Med, Dept Internal Med 1, Kerman, Iran
来源：
CHEST | 2022年 / 161卷 / 06期
关键词：
Angiotensin-converting enzyme 2 (ACE2);
D O I：
10.1016/j.chest.2022.04.063
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：529A / 529A
页数：1
相关论文
共 50 条
  • [31] Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2)
    Wiese, Owen
    Zemlin, Annalise E.
    Pillay, Tahir S.
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (05) : 285 - 290
  • [32] Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19
    Tsiambas, Evangelos
    Papanikolaou, Vasileios
    Chrysovergis, Aristeidis
    Mastronikolis, Nicholas
    Ragos, Vasileios
    Kavantzas, Nikolaos
    Lazaris, Andreas C.
    Kyrodimos, Efthymios
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2823 - 2825
  • [33] COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
    Beyerstedt, Stephany
    Casaro, Expedito Barbosa
    Rangel, Erika Bevilaqua
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (05) : 905 - 919
  • [34] Angiotensin-converting enzyme 2 (ACE2),SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
    Bourgonje, Arno R.
    Abdulle, Amaal E.
    Timens, Wim
    Hillebrands, Jan-Luuk
    Navis, Gerjan J.
    Gordijn, Sanne J.
    Bolling, Marieke C.
    Dijkstra, Gerard
    Voors, Adriaan A.
    Osterhaus, Albert D. M. E.
    van Der Voort, Peter H. J.
    Mulder, Douwe J.
    van Goor, Harry
    JOURNAL OF PATHOLOGY, 2020, 251 (03): : 228 - 248
  • [35] COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
    Stephany Beyerstedt
    Expedito Barbosa Casaro
    Érika Bevilaqua Rangel
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 905 - 919
  • [36] Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
    Zemlin, Annalise E.
    Wiese, Owen J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2020, 57 (05) : 339 - 350
  • [37] COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
    Aleksova, A.
    Ferro, F.
    Gagno, G.
    Cappelletto, C.
    Santon, D.
    Rossi, M.
    Ippolito, G.
    Zumla, A.
    Beltrami, A. P.
    Sinagra, G.
    JOURNAL OF INTERNAL MEDICINE, 2020, 288 (04) : 410 - 421
  • [38] Decreased serum levels of angiotensin converting enzyme (ACE)2 and enhanced cytokine levels with severity of COVID-19: normalisation upon disease recovery
    Mortaz, Esmaeil
    Jamaati, Hamidreza
    Roofchayee, Neda Dalil
    Sheikhzade, Hakime
    Mirenayat, Maryam
    Sadeghi, Mohsen
    Lookzadeh, Somayeh
    Dezfuli, Neda K.
    Folkerts, Gert
    Mumby, Sharon
    Garssen, Johan
    Adcock, Ian M.
    HELIYON, 2022, 8 (02)
  • [39] Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
    Clarke, Nicola E.
    Fisher, Martin J.
    Porter, Karen E.
    Lambert, Daniel W.
    Turner, Anthony J.
    PLOS ONE, 2012, 7 (04):
  • [40] Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
    Kragstrup, Tue W.
    Singh, Helene Sogaard
    Grundberg, Ida
    Nielsen, Ane Langkilde-Lauesen
    Rivellese, Felice
    Mehta, Arnav
    Goldberg, Marcia B.
    Filbin, Michael R.
    Qvist, Per
    Bibby, Bo Martin
    PLOS ONE, 2021, 16 (06):
12345